论文部分内容阅读
目的探讨舒血宁注射液联合奥扎格雷钠治疗急性脑梗死的临床疗效。方法选取灵寿县中西医结合医院2016年收治的急性脑梗死患者80例,根据随机数字表法将所有患者分为观察组与对照组,各40例。对照组患者予以舒血宁注射液治疗,观察组在对照组基础上联合奥扎格雷钠治疗,两组患者均持续治疗14 d。比较两组患者临床疗效、美国国立卫生研究院卒中量表(NIHSS)评分、日常生活能力量表(Barthel指数)及不良反应发生情况。结果观察组患者总有效率高于对照组(P<0.05)。治疗前两组患者NIHSS评分和Barthel指数比较,差异无统计学意义(P>0.05);治疗后观察组患者NIHSS评分低于对照组,Barthel指数高于对照组(P<0.05)。两组患者均未出现严重不良反应。结论舒血宁注射液联合奥扎格雷钠治疗急性脑梗死的临床疗效确切,可有效改善患者的神经功能,提高日常生活能力。
Objective To investigate the clinical efficacy of Shuxuening injection combined with ozagrel sodium in the treatment of acute cerebral infarction. Methods Eighty patients with acute cerebral infarction admitted to Integrative Medicine Hospital of Lingshou County in 2016 were enrolled. All patients were divided into observation group and control group according to random number table method, 40 cases in each group. Patients in the control group were treated with Shuxuening injection. The observation group was treated with ozagrel sodium on the basis of the control group, and both groups were treated for 14 days. The clinical efficacy, NIHSS score, Barthel index, and incidence of adverse reactions were compared between the two groups. Results The total effective rate in observation group was higher than that in control group (P <0.05). There was no significant difference in NIHSS score and Barthel index between the two groups before treatment (P> 0.05). After treatment, NIHSS score of observation group was lower than that of control group, Barthel index was higher than that of control group (P <0.05). No serious adverse reactions occurred in both groups. Conclusion Shuxuening injection combined with ozagrel sodium in the treatment of acute cerebral infarction clinical effect is exact, can effectively improve the patient’s neurological function, improve daily living ability.